Equinoxone entered the industry of Property Insurance and Casualty Insurance in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 524126, which describes it as a Property Insurance and Casualty Insurance. For further clarification, the SIC classifies this business under the code 6331 and described it as a Property Insurance and Casualty Insurance. The business provides service to the BOTH market.
To acquire more information, please contact Steve Talcott by calling (480) 705-4046 during business hours. You can also write to the business’ Single Location at 4809 East Thistle Landing Drive, Phoenix, Arizona AZ 85044. You can also visit the company’s website at equinoxone.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Equinoxone |
Representative: | Steve Talcott |
Place of Business: | 4809 East Thistle Landing Drive, Phoenix, AZ 85044 |
Contact Number: | (480) 705-4046 |
Website: | equinoxone.com |
Type of Service: | Property Insurance and Casualty Insurance |
SIC Number: | 6331 |
NAICS Number: | 524126 |
Locality: | Single Location |
Market Type: | B2B & B2C |
Began: | 2010 |
Income/Year: | Unknown |
Laborers: | 1 to 4 |
Share This Company: |
Equinoxone is a company operating from Maricopa, Arizona providing professional Property Insurance and Casualty Insurance and relevant BOTH variables. It was founded in 2010 and registered with the SIC code 6331 as Property Insurance and Casualty Insurance, and with the NAICS code 524126 as Property Insurance and Casualty Insurance.
With a current employee count of 1 to 4, Equinoxone has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Steve Talcott at (480) 705-4046 for related queries, or to locate its Single Location using the coordinates 33.312421,-111.980113.
The Single Location can also be found at the street address 4809 East Thistle Landing Drive in Phoenix, Arizona 85044 and can be engaged online through the company website at equinoxone.com, the company Twitter , and Facebook page .